During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
If the UK position is rejected, the Government could be faced with a choice between remaining in the Customs Union or accepting a hard Irish
The size of the proposed penalty has not been disclosed.
Walter Leroy Moody became the oldest US inmate put to death since executions resumed in the US in the 1970s.